BYSI Stock Analysis: Buy, Sell, or Hold?
BYSI - BeyondSpring Inc. Ordinary Shares
$1.54
-0.02 (-1.28%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When BYSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BYSI shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: BYSI shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BYSI is currently trading at $1.54, which is considered oversold relative to its 30-day fair value range of $1.55 to $1.76.
Technical Outlook: Technically, BYSI is showing sideways momentum. The price is currently testing key support at $1.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.25. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BYSI is showing sideways momentum. The price is currently testing key support at $1.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.25. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.55 -
$1.76
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 19.9% above Wall St target ($1.25)
Fair Price Analysis
30-Day Fair Range
$1.55 -
$1.76
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$1.77
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
10.54
Wall Street Target
$1.25
(-19.9%)
Revenue Growth (YoY)
14.3%
Last updated: January 31, 2026 3:01 PM ET
Data refreshes hourly during market hours. Next update: 4:01 PM
Data refreshes hourly during market hours. Next update: 4:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BYSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced BYSI Option Strategies
Professional options setups generated by AI based on today's BYSI price and gamma walls.
